ABBV vs SYK
By Alex · Tickerpine
AbbVie Inc. vs Stryker Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | SYK |
|---|---|---|
| Price | $285.64 | $307.15 |
| Market cap | $504.76B | $117.81B |
| P/E ratio | 80.5 | 31.8 |
| ROE | — | 16.51% |
| Profit margin | 9.80% | 14.43% |
| Revenue growth | 10.20% | 9.40% |
| Dividend yield | 2.42% | 1.15% |
| Beta | 0.23 | 0.78 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs SYK in plain English
- ABBV is the bigger company — about 4.3× the market cap of SYK.
- SYK is cheaper on earnings (P/E 31.8 vs 80.5).
- ABBV is growing revenue faster (10% vs 9%).
- ABBV has the higher dividend yield (2.42% vs 1.15%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
SYK return calculator
See what $1,000 in Stryker Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.